| Literature DB >> 28803781 |
Kyong-Rim Kieffer-Kwon1, Keisuke Nimura1, Suhas S P Rao2, Jianliang Xu1, Seolkyoung Jung1, Aleksandra Pekowska1, Marei Dose1, Evan Stevens1, Ewy Mathe1, Peng Dong3, Su-Chen Huang4, Maria Aurelia Ricci5, Laura Baranello6, Ying Zheng6, Francesco Tomassoni Ardori7, Wolfgang Resch1, Diana Stavreva8, Steevenson Nelson1, Michael McAndrew9, Adriel Casellas10, Elizabeth Finn11, Charles Gregory1, Brian Glenn St Hilaire4, Steven M Johnson12, Wendy Dubois13, Maria Pia Cosma14, Eric Batchelor15, David Levens6, Robert D Phair16, Tom Misteli11, Lino Tessarollo7, Gordon Hager8, Melike Lakadamyali5, Zhe Liu3, Monique Floer9, Hari Shroff10, Erez Lieberman Aiden17, Rafael Casellas18.
Abstract
50 years ago, Vincent Allfrey and colleagues discovered that lymphocyte activation triggers massive acetylation of chromatin. However, the molecular mechanisms driving epigenetic accessibility are still unknown. We here show that stimulated lymphocytes decondense chromatin by three differentially regulated steps. First, chromatin is repositioned away from the nuclear periphery in response to global acetylation. Second, histone nanodomain clusters decompact into mononucleosome fibers through a mechanism that requires Myc and continual energy input. Single-molecule imaging shows that this step lowers transcription factor residence time and non-specific collisions during sampling for DNA targets. Third, chromatin interactions shift from long range to predominantly short range, and CTCF-mediated loops and contact domains double in numbers. This architectural change facilitates cognate promoter-enhancer contacts and also requires Myc and continual ATP production. Our results thus define the nature and transcriptional impact of chromatin decondensation and reveal an unexpected role for Myc in the establishment of nuclear topology in mammalian cells. Published by Elsevier Inc.Entities:
Keywords: B cells; CTCF; Histone acetylation; chromatin remodeling; cohesin; immune response; myc; nanoscopy; nuclear architecture; transcriptome amplification
Mesh:
Substances:
Year: 2017 PMID: 28803781 PMCID: PMC5854204 DOI: 10.1016/j.molcel.2017.07.013
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970